Search

Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.

… Friday, December 14, 2012 Summary Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer. Memorial Sloan Kettering researchers have gained new understanding about how a type of white

MSK recognized National Cancer Prevention Month (February) and National Nutrition Month (March) with online educational programming highlighting the connection between diet, nutrition, and cancer.

… Wednesday, March 23, 2022 To recognize National Cancer Prevention Month (February) and National Nutrition Month (March), Memorial Sloan Kettering Cancer Center (MSK) recently offered some online educational programming for the community about the connection between diet and cancer. National Cancer Prevention

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, February 9, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:  Tobias M. Hohl Tobias M. Hohl Elected as 2022 AAAS Fellow Tobias M. Hohl, MD, PhD , Chief, infectious disease service, was elected to the 2022 class of  American Association

This year, MSK joins the National Cancer Institute and the larger cancer community in commemorating the 50th anniversary of the signing of the National Cancer Act of 1971.

… Monday, March 8, 2021 Summary This year, MSK joins the National Cancer Institute (NCI) and the larger cancer community in commemorating the 50th anniversary of the signing of the National Cancer Act of 1971. For fifty years, the National Cancer Act has helped fuel breakthroughs in fundamental biological

Memorial Sloan Kettering researchers gathered with scientists from four other institutions at Cold Spring Harbor Laboratory on Long Island in September to present and discuss projects funded by the Starr Cancer Consortium.

… Monday, December 1, 2008 Summary Memorial Sloan Kettering researchers gathered with scientists from four other institutions at Cold Spring Harbor Laboratory on Long Island in September to present and discuss projects funded by the Starr Cancer Consortium. Rockefeller University President Paul Nurse,

Gynecologic surgeon Carol Brown shared information about cancer health equity during two expert panels in February.

… Tuesday, March 8, 2022 Carol Brown , Senior Vice President, Office of the Hospital President, shared information about cancer health equity during two expert panels in February. Equity means that each person has the appropriate resources, opportunities, and support they need to live a healthy life. It

Get to know Nalini Dhingra, a postdoctoral fellow in the Sloan Kettering Institute.

… Tuesday, March 24, 2020 Summary As part of Women’s History Month, we are profiling some of MSK’s star female graduate students and postdoctoral fellows training to be leaders in their fields. Nalini Dhingra is a postdoctoral fellow in the Zhao lab  in the Sloan Kettering Institute. Was there someone

Cell biologist Michael Overholtzer explains apoptosis, a form of programmed cell death that can lead to cancer when it doesn’t function properly.

… Friday, May 16, 2014 Summary Cell biologist Michael Overholtzer explains apoptosis, a form of programmed cell death that can lead to cancer when it doesn’t function properly. The death of one tiny cell might seem like a simple thing. But the process is much more complicated than you would expect. There

Learn why MSK was once nicknamed “Radium Hospital” and what it meant for cancer treatment.

… Thursday, September 22, 2016 Summary The history of MSK as a cancer hospital is inseparable from the history of radium, one of the earliest cancer treatments. In the mountainous region of what is now the Czech Republic, along the German border, is a mining town called Joachimsthal, famous for its silver

Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.

… Monday, December 15, 2025 The U.S. Food and Drug Administration (FDA) approved 10 cancer drugs in 2025, based on clinical trials in which MSK played a pivotal role.  These approvals spanned therapies for a range of solid tumors and blood cancers and included treatments for both common and rare types